NewAmsterdam Pharma Company N.V. - Ordinary Shares (NAMS) earnings
NAMS earnings moved a median of +1.74% by the close. Quarterly and annual NAMS reports and results, each read against the price at its own news timestamp. Back to the NAMS overview →
10 measured NAMS earnings events.
Where these NAMS earnings landedvs 10 measured NAMS earnings reactions
| Middle 50% of NAMS earnings reactions | -0.70% to +7.63% |
|---|---|
| Median reaction (to close) | +1.74% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 NAMS earnings events with a measured close landed between -0.70% and +7.63%; 70% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K NewAmsterdam Pharma Co For: Dec 31 | SEC filing · Form 10-K | +0.99% | +1.33% | |
| Form 10-Q NewAmsterdam Pharma Co For: Sep 30 | SEC filing · Form 10-Q | +2.00% | +6.17% | |
| Form 10-Q NewAmsterdam Pharma Co For: Jun 30 | SEC filing · Form 10-Q | +0.72% | +9.10% | |
| Form 10-Q NewAmsterdam Pharma Co For: Mar 31 | SEC filing · Form 10-Q | +4.44% | +1.85% | |
| Form 10-K NewAmsterdam Pharma Co For: Dec 31 | SEC filing · Form 10-K | +1.62% | +8.12% | |
| Form 10-Q NewAmsterdam Pharma Co For: Sep 30 | SEC filing · Form 10-Q | +1.95% | +12.97% | |
| Form 10-Q NewAmsterdam Pharma Co For: Jun 30 | SEC filing · Form 10-Q | +0.34% | -3.21% | |
| Form 10-Q NewAmsterdam Pharma Co For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +1.63% | |
| Form 10-K NewAmsterdam Pharma Co For: Dec 31 | SEC filing · Form 10-K | +2.09% | -1.38% | |
| NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter 2023 Financial Highlights | Press release | +0.00% | -7.92% |
Keep exploring
More NAMS: analyst actions → · SEC filings → · NAMS overview →